PharmaLex US has entered into a cooperative agreement with Linical USA, Inc. The strategic alignment provides clients with a full portfolio of services necessary to conduct clinical trials in the United States while providing FDA regulatory expertise.

“We are looking forward to providing our clients with the highest quality of regulatory and clinical services as we maximize each of our individual corporate strengths,” said PharmaLex US President Andrew Verderame, MBA, RAC.